For decades, pharmacological approaches to sexual dysfunction have predominantly focused on peripheral mechanismsโspecifically, increasing blood flow to the genitals via PDE5 inhibitors like sildenafil (Viagra) and tadalafil (Cialis). However, these treatments fail to address a critical component of sexual health: desire and central nervous system arousal. Enter PT-141, also known by its generic name bremelanotide. […]
